Agency Forms Undergoing Paperwork Reduction Act Review, 54829-54830 [E9-25531]
Download as PDF
<![CDATA[
54829
Federal Register / Vol. 74, No. 204 / Friday, October 23, 2009 / Notices
‘‘Recordkeeping Requirements for
Human Food and Cosmetics
Manufactured From, Processed With, or
Otherwise Containing, Material From
Cattle,’’ published in the Federal
Register of October 11, 2006 (71 FR
59653 at 59667).
TABLE 1.—ESTIMATED ANNUAL RECORDKEEPING BURDEN1
21 CFR Section
No. of
Recordkeepers
Annual Frequency
per Recordkeeping
Total Annual
Records
Hours per
Record
Total
Domestic Facilities
189.5(c) and 700.27(c)
697
52
36,244
0.25
9,061
Foreign Facilities
189.5(c) and 700.27(c)
916
52
47,632
0.25
11,908
Total
1 There
20,969
are no capital or operating and maintenance costs associated with this collection of information.
FDA estimates that there are 697
domestic facility relationships (71 FR
59653 at 59667), and 916 foreign facility
relationships (71 FR 59653 at 59663),
consisting of the following facilities: An
input supplier of cattle-derived
materials that requires records (the
upstream facility) and a purchaser of
cattle-derived materials requiring
documentation—this may be a human
food or cosmetic manufacturer or
processor. The recordkeeping burden of
FDA’s regulations in §§ 189.5(c) and
700.27(c) is the burden of sending,
verifying, and storing documents
regarding shipments of cattle material
that is to be used in human food and
cosmetics. In this estimate of the
recordkeeping burden, we treat these
recordkeeping activities as shared
activities between the upstream and
downstream facilities. It is in the best
interests of both facilities in the
relationship to share the burden
necessary to comply with the
regulations; therefore, we estimate the
time burden of developing these records
as a joint task between the two facilities.
Thus, we estimate that this
recordkeeping burden will be about 15
minutes per week, or 13 hours per year
(71 FR 59653 at 59667), and we assume
that the recordkeeping burden will be
shared between 2 entities (i.e. the
ingredient supplier and the
manufacturer of finished products).
Therefore, the total recordkeeping
burden for domestic facilities is
estimated to be 13 hours x 697 = 9,061
hours, and the total recordkeeping
burden for foreign facilities is estimated
to be 13 hours x 916 = 11,908 hours, as
shown in table 1 of this document.
TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1
No. of
Respondents
21 CFR Section
189.5(c)(6) and 700.27(c)(6)
CPrice-Sewell on DSKGBLS3C1PROD with NOTICES
1 There
Annual Frequency
per Response
54,825
Total Annual
Responses
1
Hours per
Response
54,825
Total Hours
0.033
1,809
are no capital or operating and maintenance costs associated with this collection of information.
FDA’s regulations in §§ 189.5(c)(6)
and 700.27(c)(6) impose a reporting
burden on importers of human food and
cosmetics that are manufactured from,
processed with, or otherwise contain,
cattle material. Importers of these
products must affirm that the food or
cosmetic is manufactured from,
processed with, or does not otherwise
contain, prohibited cattle materials and
must affirm that the human food or
cosmetic was manufactured in
accordance with the applicable
requirements of §§ 189.5 or 700.27. The
affirmation is made by the importer of
record to FDA through the agency’s
Operational and Administrative System
for Import Support. Affirmation by
importers is expected to take
approximately 2 minutes per entry line.
Table 2 of this document shows that
54,825 lines of food and cosmetics that
likely contain cattle materials are
imported annually (71 FR 59653 at
59667). The annual reporting burden of
affirming whether import entry lines
VerDate Nov<24>2008
15:24 Oct 22, 2009
Jkt 220001
contain cattle-derived materials is
estimated to take 1,809 hours annually
(54,825 lines x 2 minutes per line).
Dated: October 16, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9–25537 Filed 10–22–09; 8:45 am]
BILLING CODE 4160–01–S
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–10–0789]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
Program Effectiveness Evaluation of
Workplace Intervention for Intimate
Partner Violence (IPV)—[OMB# 0920–
0789] [exp. 12/31/09]—Extension—
National Center for Injury Prevention
and Control (NCIPC), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Intimate partner violence (IPV) affects
a substantial number of Americans, and
there has recently been increasing
recognition of the impact it has on the
workplace. In addition to direct impacts
(batterers often stalk or even attack IPV
E:\FR\FM\23OCN1.SGM
23OCN1
54830
Federal Register / Vol. 74, No. 204 / Friday, October 23, 2009 / Notices
victims at their place of work), IPV has
indirect impacts on the workplace
environment through lost productivity
due to medical leave, absenteeism, and
fear and distraction on the part of
victims and coworkers. The Centers for
Disease Control and Prevention (CDC)
contracted with RTI International (RTI)
to evaluate an ongoing workplace IPV
prevention program being implemented
at a national corporation. The purpose
of the proposed evaluation is to
document in detail the workplace IPV
prevention activities delivered by the
company, to determine the impact of
these activities on short-term and longterm outcomes, and to determine the
cost-effectiveness of the program. All
managers at the corporate office of the
corporation have been screened to
assess training experiences. More in-
depth surveys were conducted with
managers who had not completed the
corporation’s IPV training. We have
surveyed managers at baseline, and 6
months later. Manager surveys focus on
knowledge/awareness of IPV and
company resources for IPV and number
of referrals for IPV assistance. This
extension is requested to cover the 12month follow-up administration of this
survey. Due to unexpected delays at the
evaluation site and an inability to field
the 6-month follow up survey with
managers when originally scheduled,
we will need to push the timeline for
12-month follow up back approximately
3 months.
We have also surveyed employees of
those managers who completed the
baseline survey using an anonymous
Web-based survey at baseline. These
employees will also be surveyed 12
months later (during the extension
period) to assess their self-evaluated
productivity, absenteeism, and
perceptions of manager behavior. We
will compare the responses of managers
(and their employees) who received the
IPV training in the study period (i.e.,
sometime between the baseline and 12
month surveys) with untrained
managers. The study will provide CDC
and employers information about the
potential effectiveness and costeffectiveness of workplace IPV
intervention strategies.
There are no costs to respondents
except their time to participate in the
interview. The estimated total
annualized burden hours are 1125.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Respondents
Manager .......................................................................................................................................
Employee .....................................................................................................................................
Dated: October 16, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–25531 Filed 10–22–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Proposed Project: Targeted Capacity
Expansion Program for Substance
Abuse Treatment and HIV/AIDS
Services (TCE–HIV)—NEW
CPrice-Sewell on DSKGBLS3C1PROD with NOTICES
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
VerDate Nov<24>2008
15:24 Oct 22, 2009
Jkt 220001
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
This data collection is to study the
risk and protective factors related to
substance use and HIV. The primary
purpose of the Project is to
conceptualize, plan, and implement a
multi-site evaluation to investigate the
process, outcome, and impact of
substance abuse treatment and HIV/
AIDS services provided by 49 SAMHSA
grantees. The grantees’ focus is on
enhancing and expanding substance
abuse treatment and/or outreach and
pretreatment services in conjunction
with HIV/AIDS services in African
American, Hispanic/Latino, and other
racial and ethnic minority communities.
A multi-stage approach has been used to
develop the appropriate theoretical
framework, conceptual model,
evaluation design and protocols, and
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
500
1500
Number of
responses per
respondent
3
1
Average
burden per
response
(in hours)
30/60
15/60
data collection instrumentation. Process
and outcome measures have been
developed to fully capture community
and contextual conditions, the scope of
the TCE–HIV Grantee program
implementation and activities, and
client outcomes. A mixed-method
approach (survey, semi-structured
interviews, focus groups) will be used,
for example, to examine collaborative
community linkages established
between grantees and other service
providers (e.g., primary health care,
medical services for PLWHA, substance
abuse recovery support services),
determine which program models and
what type and amount of client
exposure to services contribute to
significant changes in substance abuse
and HIV/AIDS risk behaviors of the
targeted populations, and determine the
impact of the TCE–HIV services on
providers, clients, and communities.
The data collection for the project will
be conducted bi-annually (i.e., every
other year during the 4 year period) and
the client outcome data collection is
ongoing throughout the project and will
be collected at baseline, discharge and
6 months post baseline for all treatment
clients. The respondents are clinicbased social workers and counselors
(e.g., social workers, licensed alcohol
and drug counselors, licensed clinical
professional counselors, licensed
E:\FR\FM\23OCN1.SGM
23OCN1
]]>Agencies
[Federal Register Volume 74, Number 204 (Friday, October 23, 2009)]
[Notices]
[Pages 54829-54830]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-25531]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-10-0789]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-5806.
Written comments should be received within 30 days of this notice.
Proposed Project
Program Effectiveness Evaluation of Workplace Intervention for
Intimate Partner Violence (IPV)--[OMB 0920-0789] [exp. 12/31/
09]--Extension--National Center for Injury Prevention and Control
(NCIPC), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Intimate partner violence (IPV) affects a substantial number of
Americans, and there has recently been increasing recognition of the
impact it has on the workplace. In addition to direct impacts
(batterers often stalk or even attack IPV
[[Page 54830]]
victims at their place of work), IPV has indirect impacts on the
workplace environment through lost productivity due to medical leave,
absenteeism, and fear and distraction on the part of victims and
coworkers. The Centers for Disease Control and Prevention (CDC)
contracted with RTI International (RTI) to evaluate an ongoing
workplace IPV prevention program being implemented at a national
corporation. The purpose of the proposed evaluation is to document in
detail the workplace IPV prevention activities delivered by the
company, to determine the impact of these activities on short-term and
long-term outcomes, and to determine the cost-effectiveness of the
program. All managers at the corporate office of the corporation have
been screened to assess training experiences. More in-depth surveys
were conducted with managers who had not completed the corporation's
IPV training. We have surveyed managers at baseline, and 6 months
later. Manager surveys focus on knowledge/awareness of IPV and company
resources for IPV and number of referrals for IPV assistance. This
extension is requested to cover the 12-month follow-up administration
of this survey. Due to unexpected delays at the evaluation site and an
inability to field the 6-month follow up survey with managers when
originally scheduled, we will need to push the timeline for 12-month
follow up back approximately 3 months.
We have also surveyed employees of those managers who completed the
baseline survey using an anonymous Web-based survey at baseline. These
employees will also be surveyed 12 months later (during the extension
period) to assess their self-evaluated productivity, absenteeism, and
perceptions of manager behavior. We will compare the responses of
managers (and their employees) who received the IPV training in the
study period (i.e., sometime between the baseline and 12 month surveys)
with untrained managers. The study will provide CDC and employers
information about the potential effectiveness and cost-effectiveness of
workplace IPV intervention strategies.
There are no costs to respondents except their time to participate
in the interview. The estimated total annualized burden hours are 1125.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Respondents Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Manager......................................................... 500 3 30/60
Employee........................................................ 1500 1 15/60
----------------------------------------------------------------------------------------------------------------
Dated: October 16, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E9-25531 Filed 10-22-09; 8:45 am]
BILLING CODE 4163-18-P
